These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25737146)

  • 21. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
    J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea.
    Won EJ; Shin JH; Kim SH; Choi MJ; Byun SA; Kim MN; Lee WG; Lee K; Uh Y; Shin MG; Suh SP
    Med Mycol; 2018 Jun; 56(4):501-505. PubMed ID: 28992138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model.
    Kupfahl C; Heinekamp T; Geginat G; Ruppert T; Härtl A; Hof H; Brakhage AA
    Mol Microbiol; 2006 Oct; 62(1):292-302. PubMed ID: 16956378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation.
    Guinea J; Peláez T; Alcalá L; Ruiz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3495-7. PubMed ID: 16048968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gliotoxin production by clinical and environmental Aspergillus fumigatus strains.
    Kupfahl C; Michalka A; Lass-Flörl C; Fischer G; Haase G; Ruppert T; Geginat G; Hof H
    Int J Med Microbiol; 2008 Apr; 298(3-4):319-27. PubMed ID: 17574915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Candidates for virulence factors of Aspergillus fumigatus].
    Watanabe A; Hashimoto Y; Higurashi H; Ochiai E; Toyotome T; Nagayoshi M; Kamei K
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(4):263-7. PubMed ID: 19001751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic profiling of the antifungal drug response of Aspergillus fumigatus to voriconazole.
    Amarsaikhan N; Albrecht-Eckardt D; Sasse C; Braus GH; Ogel ZB; Kniemeyer O
    Int J Med Microbiol; 2017 Oct; 307(7):398-408. PubMed ID: 28811086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus?
    Sugui JA; Vinh DC; Nardone G; Shea YR; Chang YC; Zelazny AM; Marr KA; Holland SM; Kwon-Chung KJ
    J Clin Microbiol; 2010 Jan; 48(1):220-8. PubMed ID: 19889894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease.
    Alhambra A; Catalán M; Moragues MD; Brena S; Pontón J; Montejo JC; del Palacio A
    Rev Iberoam Micol; 2008 Dec; 25(4):246-9. PubMed ID: 19071895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
    Misra R; Malik A; Singhal S
    Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
    Drago M; Scaltrito MM; Cariani L; Morace G
    J Chemother; 2004 Oct; 16(5):474-8. PubMed ID: 15565915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.
    Staab JF; Kahn JN; Marr KA
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4992-8. PubMed ID: 20855747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus.
    Bauer J; Gareis M; Bott A; Gedek B
    J Med Vet Mycol; 1989; 27(1):45-50. PubMed ID: 2474066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
    Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Cuenca-Estrella M; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1244-51. PubMed ID: 18212093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
    J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
    Amorim A; Guedes-Vaz L; Araujo R
    Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.